SANOFI

SAN

Delayed - 09/23 05:27:29 am
87.03EUR	+2.68%

Prev.	84.7600
Open	85.3700
High	87.0700
Low	85.2900
Volume	569 705

49m ago	Sanofi : and GSK sign agreements with the Government of Canada to supply up...
1h ago	Drafting For Multiple Jurisdictions Miniseries: Part 1 - Grace Period Provisions
16h ago	Sanofi : CHMP recommends approval of Supemtek® (quadrivalent recombinant...
16h ago	Sanofi : GSK to Supply Adjuvanted Covid-19 Vaccine to Canadian Government

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Bullish
Resistance	88,7	94,3	94,1
Spread/Res.	-1,9%	-7,7%	-7,5%
Spread/Supp.	4,1%	13%	4,1%
Support	83,6	77,0	83,6

Sales 2020	36 697 M 42 910 M 42 910 M
Net income 2020	11 700 M 13 681 M 13 681 M
Net Debt 2020	8 301 M 9 706 M 9 706 M
P/E ratio 2020	9,17x
Yield 2020	3,76%

Capitalization	106 B 125 B 125 B
EV / Sales 2020	3,13x
EV / Sales 2021	2,89x
Nbr of Employees	100 409
Free-Float	89,0%

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (84.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies,...

>> Read more

Sector :

Pharmaceuticals - NEC

Calendar :

2020-09-23 Presentation

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	25
Average target price	105,54 €
Last Close Price	84,76 €
Spread / Highest target	44,9%
Spread / Average Target	24,5%
Spread / Lowest Target	0,28%